Skip to main content
. 2024 Aug 15;21(8):1070. doi: 10.3390/ijerph21081070

Table 1.

Yearly weighted prevalence of chronic respiratory disease among AI/AN and white populations in AI/AN-high vs. AI/AN-low regions.

Weighted Prevalence (95% CI)
AI/AN White
Year AI/AN-High AI/AN-Low p Value AI/AN-High AI/AN-Low p Value
2019 20.7 (18.3–23.2) 28.8 (24.9–33.0) 0.001 18.4 (17.8–19.0) 19.7 (19.4–20.0) 4.12 × 10−4
2018 23.5 (20.6–26.6) 31.8 (27.7–36.3) 0.002 17.8 (17.2–18.4) 19.3 (19.0–19.7) 2.93 × 10−5
2017 20.9 (18.7–23.2) 31.5 (27.8–35.4) 1.55 × 10−6 17.5 (16.9–18.1) 19.3 (18.9–19.6) 4.67 × 10−7
2016 22.4 (19.9–25.1) 26.2 (23.1–29.5) NS (0.079) 16.7 (16.2–17.2) 18.4 (18.1–18.7) 1.60 × 10−7
2015 19.7 (17.0–22.8) 31.2 (27.8–34.9) 8.48 × 10−7 17.3 (16.8–17.9) 18.5 (18.2–18.8) 3.93 × 10−4
2014 19.9 (17.9–22.2) 28.4 (25.1–32.0) 2.41 × 10−5 16.7 (16.2–17.2) 18.3 (18.0–18.6) 3.07 × 10−8
2013 22.5 (19.6–25.7) 28.1 (24.7–31.7) 0.019 17.2 (16.6–17.8) 18.4 (18.1–18.7) 4.57 × 10−4
2012 19.0 (16.8–21.3) 28.8 (25.3–32.5) 2.47 × 10−6 15.5 (15.1–16.0) 17.2 (16.9–17.5) 8.14 × 10−9
2011 19.9 (17.4–22.7) 24.9 (21.8–28.3) 0.019 16.3 (15.7–16.8) 17.6 (17.3–17.8) 8.43 × 10−5

p Value: p values were obtained using the Rao–Scott χ2 test. NS: not significant.